| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2911 |
| Trial ID | NCT05212584 |
| Disease | T-Cell Acute Lymphoblast Leukemia/Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | iCell Gene Therapeutics |
| Other ID(s) | ICG170-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||